Shields Paul

Avg. Two Year Performance

No purchase track record
47% Avg. Sale Return
21% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return18%(12%)(38%)(80%)0%
Purchase Success Rate1 of 10 of 10 of 10 of 10 of 1
Average Sale Return(< 1%)12%23%39%47%
Sale Success Rate2 of 44 of 44 of 44 of 44 of 4
Drugs » Biotechnology

Vice Pres. Mfg.:

Holdings: 13.1K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--